Vladimir Savransky Selected Research

Anthrax Vaccines (Vaccines, Anthrax)

1/2021	Efficacy of the AV7909 anthrax vaccine candidate in guinea pigs and nonhuman primates following two immunizations two weeks apart.
1/2020	Development of a guinea pig inhalational anthrax model for evaluation of post-exposure prophylaxis efficacy of anthrax vaccines.
10/2019	Comparative immunogenicity and efficacy of thermostable (lyophilized) and liquid formulation of anthrax vaccine candidate AV7909.
1/2017	Correlation between anthrax lethal toxin neutralizing antibody levels and survival in guinea pigs and nonhuman primates vaccinated with the AV7909 anthrax vaccine candidate.
4/2013	Pathology and pathophysiology of inhalational anthrax in a guinea pig model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vladimir Savransky Research Topics

Disease

7	Anthrax 01/2021 - 04/2013
7	Hypoxia (Hypoxemia) 04/2011 - 05/2006
5	Inflammation (Inflammations) 01/2021 - 10/2007
3	Dyslipidemias (Dyslipidemia) 04/2011 - 06/2007
3	Atherosclerosis 11/2008 - 02/2007
2	Body Weight (Weight, Body) 10/2021 - 07/2020
2	Poisoning 07/2021 - 01/2021
2	Edema (Dropsy) 01/2021 - 04/2013
2	Necrosis 04/2013 - 02/2009
2	Hypercholesterolemia 10/2007 - 05/2006
2	Septic Shock (Toxic Shock Syndrome) 03/2004 - 07/2003
1	Hemorrhage 04/2013
1	Hyperlipidemias (Hyperlipidemia) 04/2011
1	Diabetes Mellitus 02/2009
1	Liver Diseases (Liver Disease) 02/2009
1	Sleep Apnea Syndromes (Sleep Apnea) 02/2009
1	Apnea 02/2009
1	Fatty Liver 02/2009
1	Insulin Resistance 02/2009
1	Obesity 04/2007
1	Hyperglycemia 04/2007
1	Obstructive Sleep Apnea 02/2007
1	Hypertriglyceridemia 05/2006
1	Acute Kidney Injury (Acute Renal Failure) 05/2006
1	Foodborne Diseases 03/2004
1	Shock 07/2003

Drug/Important Bio-Agent (IBA)

5	VaccinesIBA 10/2021 - 01/2017
5	Anthrax Vaccines (Vaccines, Anthrax)IBA 01/2021 - 04/2013
5	CholesterolIBA 11/2008 - 05/2006
3	Neutralizing AntibodiesIBA 01/2021 - 01/2017
3	EnzymesIBA 02/2009 - 06/2007
3	LipidsIBA 10/2007 - 05/2006
2	Cyanides (Isocyanides)IBA 07/2021 - 01/2021
2	isoamyl nitriteIBA 07/2021 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 07/2020 - 05/2006
2	AerosolsIBA 10/2019 - 04/2013
2	Insulin (Novolin)FDA Link 02/2009 - 04/2007
2	stearoyl-coenzyme A (stearoyl-CoA)IBA 11/2008 - 06/2007
2	Triglycerides (Triacylglycerol)IBA 11/2008 - 04/2007
2	Lipoproteins (Lipoprotein)IBA 11/2008 - 06/2007
2	LDL CholesterolIBA 11/2008 - 06/2007
2	Sterol Regulatory Element Binding ProteinsIBA 10/2007 - 05/2006
2	staphylococcal enterotoxin BIBA 03/2004 - 07/2003
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2021
1	anthrax toxin (anthrax lethal factor)IBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	Pregnancy-Associated alpha 2-Macroglobulins (alpha 2 Macroglobulin)IBA 07/2020
1	Orosomucoid (Seromucoid)IBA 07/2020
1	Monoclonal AntibodiesIBA 05/2020
1	AntitoxinsIBA 05/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2020
1	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2020
1	ProMune (CpG 7909)IBA 01/2017
1	FibrinIBA 04/2013
1	LeptinIBA 04/2011
1	Blood Glucose (Blood Sugar)IBA 02/2009
1	C-Reactive ProteinIBA 02/2009
1	Acetaminophen (Paracetamol)FDA LinkGeneric 02/2009
1	Oxygen (Dioxygen)IBA 02/2009
1	Messenger RNA (mRNA)IBA 11/2008
1	Oxyhemoglobins (Oxyhemoglobin)IBA 11/2008
1	VLDL CholesterolIBA 11/2008
1	Antisense OligonucleotidesIBA 11/2008
1	SREBP cleavage-activating proteinIBA 10/2007
1	Transcription Factors (Transcription Factor)IBA 10/2007
1	GlycogenIBA 04/2007
1	Stearoyl-CoA DesaturaseIBA 05/2006
1	ChemokinesIBA 05/2006

Therapy/Procedure

2	Therapeutics 05/2020 - 01/2020
1	Bariatric Surgery 02/2009
1	Intranasal Administration 07/2003